Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology

NeuroToxicology

Volumn 31, Issue 5, 2010, Pages 485-492

  Apland, James P ^a   Figueiredo, Taiza H ^b   Qashu, Felicia ^b   Aroniadou Anderjaska, Vassiliki ^b   Souza, Adriana P ^b   Braga, Maria F M ^b  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

Amygdala; Hippocampus; Nerve agents; Neuronal degeneration; Soman; Status epilepticus

Indexed keywords

SOMAN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN REGION; BRAIN TISSUE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; EPILEPTIC STATE; EXPOSURE; HIPPOCAMPUS; MALE; NERVE CELL DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SEIZURE;

AMYGDALA; ANIMALS; CHOLINESTERASE INHIBITORS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FLUORESCEINS; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SOMAN; TIME FACTORS;

RATTUS;

EID: 77956228961     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.05.014     Document Type: Article

References (41)

1. Akaike K., Tanaka S., Hideshi Tojo H., Fukumoto S., Imamura S., Takigawa M. Kainic acid-induced dorsal and ventral hippocampal seizures in rats. Brain Res 2001, 900:65-71.
2. Apland J.P., Aroniadou-Anderjaska V., Braga M.F.M. Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro. Neuroscience 2009, 159:380-389.
3. Aroniadou-Anderjaska V., Figueiredo Y.H., Apland J.P., Qashu F., Braga M.F.M. Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology 2009, 30:772-776.
4. Baille V., Clarke P.G., Brochier G., Dorandeu F., Verna J.M., Four E., et al. Soman-induced convulsions: the neuropathology revisited. Toxicology 2005, 215:1-24.
5. Bajgar J., Sevelova L., Krejcova G., Fusek J., Vachek J., Kassa J., et al. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal Toxicol 2004, 16:497-507.
6. Bajgar J. Complex view on poisoning with nerve agents and organophosphates. Acta Medica (Hradec Kralove) 2005, 48:3-21.
7. Barthold C.L., Schier J.G. Organic phosphorus compounds-nerve agents. Crit Care Clin 2005, 21:673-689.
8. Baze W.B. Soman-induced morphological changes: an overview in the nonhuman primate. J Appl Toxicol 1993, 13:173-177.
9. Bouilleret V., Schwaller B., Schurmans S., Celio M.R., Fritschy J.M. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin. Neuroscience 2000, 97:47-58.
10. Brown M.A., Brix K.A. Review of health consequences from high, intermediate, and low-level exposure to organophosphorus nerve agents. J Appl Toxicol 1998, 6:393-408.
11. Choi Y.S., Lin S.L., Lee B., Kurup P., Chao H.Y., Naegele J.R., et al. Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase. J Neurosci 2007, 27:2999-3009.
12. Collombet J.M., Four A., Fauquette W., Burckhart M.F., Masqueliez C., Bernabe D., et al. Soman poisoning induces delayed astrogliotic scarand angiogenesis in damaged mouse brain areas. Neurotoxicology 2007, 28:38-48.
13. Freund T.F., Ylinen A., Miettinen R., Pitkanen A., Lahtinen H., Baimbridge K.G., et al. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability. Brain Res Bull 1992, 28:27-38.
14. Gilbert M., Racine R.J., Smith G.K. Epileptiform burst responses in ventral vs dorsal hippocampal slices. Brain Res 1985, 361:389-391.
15. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. Neurol Sci 1990, 98:99-106.
16. Joosen M.J., Jousma E., van den Boom T.M., Kuijpers W.C., Smit A.B., Lucassen P.J., et al. Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoning. Neurotoxicology 2009, 30:72-80.
17. Kadar T., Cohen G., Sahar R., Alkalai D., Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum Exp Toxicol 1992, 11:517-523.
18. Kadar T., Shapira S., Cohen G., Sahar R., Alkalay D., Raveh L. Sarin-induced neuropathology in rats. Hum Exp Toxicol 1995, 14:252-259.
19. Kassa J., Koupilova M., Herink J., Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica (Hradec Kralove) 2001, 44:21-27.
20. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Sentenac-Roumanou H., et al. Involvement of glutamatergic system of amygdala in generalized seizures induced by soman: comparison with the hippocampus. CR Acad Sci III 1991, 313:421-426.
21. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., et al. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci Lett 1992, 139:104-107.
22. Layish I., Krivoy A., Rotman E., Finkelstein A., Tashma Z., Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning. Isr Med Assoc J 2005, 7:182-187.
23. López-Muñoz F., Alamo C., Guerra J.A., García-García P. The development of neurotoxic agents as chemical weapons during the National Socialist period in Germany. Rev Neurol 2008, 47:99-106.
24. McDonough J.H., Smith R.F., Smith C.D. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Neurobehav Toxicol Teratol 1986, 8:179-187.
25. McDonough J.H., Dochterman W., Smith C.D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 15:123-132.
26. McDonough J.H., Shih T.-M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev 1997, 21:559-579.
27. McDonough J.H., Zoeffel L.D., McMonagle J., Copeland T.L., Smith C.D., Shih T.-M. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res 2000, 38:1-14.
28. Meyer A., Beck E., Shepherd M. Unusually severe lesions in the brain following status epilepticus. J Neurol Neurosurg Psychiat 1955, 18:24-33.
29. Morita H., Yanagisawa N., Nakajima T., Shimizu M., Hirabayashi H., Okudera H., et al. Sarin poisoning in Matsumoto, Japan. Lancet 1995, 346:260-261.
30. Myhrer T., Andersen J.M., Nguyen N.H., Aas P. Soman-induced convulsions in rats terminated with pharmacological agents after 45min: neuropathology and cognitive performance. Neurotoxicology 2005, 26:39-48.
31. Myhrer T., Enger S., Aas P. Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. Basic Clin Pharmacol Toxicol 2006, 98:184-191.
32. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Elsevier, New York, NY. 4th ed.
33. Pitkänen A., Tuunanen J., Kalviainen R., Partanen K., Salmenpera T. Amygdala damage in experimental and human temporal lobe epilepsy. Epilepsy Res 1998, 32:233-253.
34. Qashu F., Figueiredo T.H., Aroniadou-Anderjaska V., Apland J.P., Braga M.F.M. Diazepam administration after prolonged status epilepticus reduces neurodegeneration in the amygdala but not in the hippocampus during epileptogenesis. Amino Acids 2010, 38:189-197.
35. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencaphal Clin Neurophysiol 1972, 32:281-294.
36. Racine R.J., Rose P.A., Burnham W.M. After discharge thresholds and kindling rates in dorsal and ventral hippocampus and dentate gyrus. Can J Neurol Sci 1977, 4:273-278.
37. Sah P., Faber E.S., Lopez de Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
38. Shih T.-M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol 2003, 188:69-80.
39. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. TiPS 1997, 18:183-185.
40. Tuunanen J., Holonen T., Pitkanen A. Status epilepticus causes selective regional damage and loss of GABAergic neurons in the rat amygdaloid complex. Eur J Neurosci 1996, 8:2711-2725.
41. Wu C.P., Cheung G., Rakhshani N., Parvardeh S., Nassiri Asl M., Huang H.L., et al. CA3 neuronal activities of dorsal and ventral hippocampus are differentially altered in rats after prolonged post-ischemic survival. Neuroscience 2005, 130:527-539.